← Back to Clinical Trials
Recruiting NCT05677243
NCT05677243 Observational Study on the Treatment of Trigeminal Neuralgia by Radiosurgery
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT05677243 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Princesse Grace |
| Condition | Trigeminal Neuralgia |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2021-12-15 |
| Primary Completion | 2026-12 |
Trial Parameters
Condition Trigeminal Neuralgia
Sponsor Centre Hospitalier Princesse Grace
Study Type OBSERVATIONAL
Phase N/A
Enrollment 150
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2021-12-15
Completion 2026-12
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
This study aims to evaluate the outcome of patient treated by radiosurgery on LINAC with high dose rate for classical trigeminal neuralgia
Eligibility Criteria
Inclusion Criteria: * Classical trigeminal neuralgia according the International Classification of Headache Disorders * Trigeminal neuralgia resistant to the maximum tolerated medical therapy, with pain intensity according to the Barrow Neurological Institute (BNI) score IV or V. * Patients aged \> 18 Exclusion Criteria: * Patients suffering from secondary Trigeminal neuralgia (tumour in the cerebellopontine angle, arteriovenous malformation or multiple sclerosis) * Previous history of radiosurgery procedure
Related Trials
NCT02910323
The Will Erwin Headache Research Center - Cluster Headache Study
View Trial →
NCT05677243
Observational Study on the Treatment of Trigeminal Neuralgia by Radiosurgery
View Trial →
NCT05051072
Assessment in Patients With Essential Trigeminal Neuralgia of Nerve Involvement by MRI in DTI and Fu
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology